Trade Summary

3 days ago, Burnett Patrick, serving as See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 1,697 shares at $29.20 per share, for a total transaction value of $49,560.00. Following this transaction, Burnett Patrick now holds 96,610 shares of ARQT.

This sale represents a 2.00% decrease in Burnett Patrick's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, December 31, 2025 and publicly disclosed via SEC Form 4 filing on Friday, January 2, 2026, 2 days after the trade was made.

Arcutis Biotherapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.